Skip to content

Clinical trials

Withdrawn Phase 2 Burkitt Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 2 Status: Withdrawn Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20061
20071
20101
20131
20141
20163
20182
20191
20201
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Masonic Cancer Center, University of Minnesota2
University of California, San Francisco2
AIDS Malignancy Consortium1
Abramson Cancer Center at Penn Medicine1
Dorothy Sipkins, MD, PhD1
Hoag Memorial Hospital Presbyterian1
Ludwig-Maximilians - University of Munich1
Novartis Pharmaceuticals1
Rutgers, The State University of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma18
Lymphoma, Large B-Cell, Diffuse10
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Lymphoma7
Lymphoma, Follicular7
Lymphoma, Mantle-Cell7
Lymphoma, Non-Hodgkin7
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, B-Cell, Marginal Zone6
Lymphoma, Large-Cell, Immunoblastic6

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.